---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-023119"
form_type: "8-K"
ticker: "INDP"
cik: "0001857044"
company_name: "Indaptus Therapeutics, Inc."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:41:48.836354+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# Indaptus stockholders approve amended 2021 stock plan at annual meeting

## Summary
- Three Class III directors elected: Roger J. Pomerantz, Michael J. Newman, Jeffrey A. Meckler.
- Ratification of Haskell & White LLP as independent auditor for fiscal 2024 approved (3,805,215 FOR vs 469,553 AGAINST).
- Amendment to 2021 Stock Incentive Plan approved, increasing shares available and extending evergreen provision (1,881,194 FOR vs 501,555 AGAINST).
- Quorum of 4,277,437 shares (50.09% of outstanding) present at June 6, 2024 meeting.
- Plan amendment restatement effective June 6, 2024; full text filed as Exhibit 10.1.

## SEC filing metadata
- accession: 0001493152-24-023119
- form_type: 8-K
- ticker: INDP
- cik: 0001857044
- company_name: Indaptus Therapeutics, Inc.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1857044/000149315224023119/0001493152-24-023119-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1857044/000149315224023119/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-023119
- JSON: https://secwatch.observer/filing/0001493152-24-023119.json
- Plain text: https://secwatch.observer/filing/0001493152-24-023119.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.